Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
WELLBUTRIN XL
Generic name / active ingredient
bupropion hydrochloride
Dosage-form class
WELLBUTRIN XL bupropion hydrochloride extended-release oral tablets: current product-identity and supply information lists 150 mg and 300 mg; 450 mg appears only in dosing and study text, not as a current product package strength.
Route
Oral
Record reviewed
2026-08-28

Copy from the pack in hand

Source-linked reading points

  • Check WELLBUTRIN XL, bupropion hydrochloride, the XL extended-release oral tablet, the actual labelled amount per unit, NDC, pack and target market together. Current product-identity and supply information lists only 150 mg and 300 mg. A 450 mg figure elsewhere in the label belongs to dosing or study text, not a third product package and not a webpage instruction for anyone's tablet count, interval or daily total.
  • The U.S. label has a boxed warning about suicidal thoughts and behaviours associated with antidepressants in children, adolescents and young adults, and calls for close observation of changes. This is a cue for reading, communication and prompt local professional support, not a webpage diagnosis, prescription, stopping or care decision for anyone. With thoughts of self-harm or harm to others, a severe behavioural or mood change, or any urgent concern, prioritise local emergency medical and crisis support.
  • The label warns about seizure risk. Do not self-combine, alternate on different days, make up a dose, split, crush or substitute because another pack also says bupropion, relates to mood or smoking cessation, or has a nearby milligram number. Take prescription medicines, OTC products, supplements and actual packs to a pharmacist or prescribing team for item-by-item review.
  • With breathing difficulty, swelling of the face or tongue, fainting, a seizure, inability to wake, chest discomfort, a serious fall or another acute serious concern, prioritise local emergency medical support; do not wait for a website search or self-counteract with another medicine.

Reviewed presentation examples — compare every field

  • Bupropion hydrochloride 150 mg per tablet; 30-tablet bottle (NDC 0187-0730-30)NDC 0187-0730-30
  • Bupropion hydrochloride 300 mg per tablet; 30-tablet bottle (NDC 0187-0731-30)NDC 0187-0731-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-28
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image